A late-stage clinical trial found that, when combined with an SMN2-targeting drug, Isembyld caused young patients’ motor ...
U.S. officials declare an end to record-setting cyclospora outbreak, but its origin is still unknown
The largest cyclospora food poisoning outbreak in U.S. history is over, U.S. health officials said, but questions remain over ...
Platinum chemotherapy's long-term effects, surprising heart failure drug failures, and more biotech news from The Readout ...
A newly approved AI tool can scan EKGs for severe heart attacks and, the company says, for rarer patterns indicating blocked ...
New Medicaid rules use allow use of tiers to determine work exemptions. Advocates fear complex guidelines could cause ...
About four dozen children who attended a community party in August 2025 later developed skin and soft tissue lesions and ...
Novartis investors are stepping up scrutiny of the company's dealmaking after setbacks to drugs it acquired through mergers ...
An E.U. AG recommended annulling part of a directive that requires drugmakers to finance 80% of the costs of wastewater ...
Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...
The Trump administration is promising to send $500 refund checks to nearly 1 million people with Affordable Care Act health ...
Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more
A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall ...
The pharma industry invested billions of dollars to develop drugs heralded as the next era in the treatment of heart disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results